Urology News and Research

Latest Urology News and Research

FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis

Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration approval of SIMPONI ARIATM (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.

19 Jul 2013

Both milky spots and fat cells in omentum promote ovarian cancer metastases

Cancer researchers have wondered why ovarian cancer cells are so attracted to the abdominal cavity, especially the omentum, with the hope that such an understanding could lead to better disease management or even prevention.

18 Jul 2013

Thomas Jefferson University Hospital among nation's best hospitals

Thomas Jefferson University Hospital has been named to U.S. News & World Report's most exclusive and influential list: Best Hospitals 2013-14 Honor Roll. Jefferson's first-ever honor roll ranking at number 17, places it among an elite group of the nation's top hospitals, chosen for the breadth and depth of clinical excellence.

17 Jul 2013

U.S. News & World Report ranks UC San Diego Health System among nation’s best hospitals

UC San Diego Health System is once again ranked among the nation's best in U.S. News & World Report's 2013-14 "America's Best Hospitals" issue. The magazine placed UC San Diego Health System #1 in the San Diego metropolitan area with national rankings in 10 specialties—placing it among the country's most prestigious institutions.

17 Jul 2013

Houston Methodist Hospital again named No. 1 hospital in Texas

Houston Methodist Hospital, formerly known as The Methodist Hospital, ranked among the country's top hospitals in 12 specialties in U.S. News & World Report's 2013 America's "Best Hospitals" issue, and again was named the No. 1 hospital in Texas.

17 Jul 2013

UCSF Medical Center named one of nation's premier hospitals for 12th consecutive year

UCSF Medical Center ranks among the nation's premier hospitals for the 12th consecutive year and is the best in Northern California, according to the 2013-14 America's Best Hospitals survey conducted by U.S. News & World Report.

17 Jul 2013

TAp73 protein frequently overexpressed in wide range of human tumors

They say you can pick your friends, but not your family. The same may hold true for related proteins. The protein TAp73 is a relative of the well-known, tumor-suppressor protein p53. It shares extensive common gene sequences with p53 and, as suggested by some previous studies, it may function similar to p53 to prevent tumor formation.

17 Jul 2013

OncoGenex completes enrollment in OGX-427 Phase 2 trial for treatment of metastatic bladder cancer

OncoGenex Pharmaceuticals, Inc. today announced that enrollment has been completed in Borealis-1, a company-sponsored, randomized, placebo-controlled Phase 2 trial of OGX-427 in combination with first-line gemcitabine and cisplatin in patients with metastatic bladder cancer.

16 Jul 2013

Actavis’ Lamictal ODT drug receives FDA approval for treatment of epilepsy and bipolar disorder

Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.

16 Jul 2013

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.

16 Jul 2013

Proteins involved in immunity produce cancer-causing DNA mutations, study finds

A set of proteins involved in the body's natural defenses produces a large number of mutations in human DNA, according to a study led by researchers at the National Institutes of Health. The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.

15 Jul 2013

Actavis receives FDA approval for Opana ER tablets

Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Oxymorphone Hydrochloride Extended-release Tablets, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg.

15 Jul 2013

Researchers discover that APOBEC3B is important cancer mutagen

Researchers at the University of Minnesota have discovered that a human antiviral enzyme causes DNA mutations that lead to several forms of cancer.

15 Jul 2013

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer: an interview with Dr. Stephen Williams of St. Joseph Hospital in Orange

Robotic RPLND utilizes laparoscopy combined with robotic technology to perform dissection and removal of lymph node tissue in the retroperitoneum both as a staging as well as therapeutic procedure for patients with testicular cancer.

10 Jul 2013

Robotic ultrasound to identify tumors during kidney cancer surgery gains acceptance among surgeons

While the use of ultrasound to identify tumors during kidney cancer surgery is gaining acceptance, a research team at Henry Ford Hospital has successfully taken it a step further by showing an added benefit when the procedure is done robotically.

10 Jul 2013

Bioniche, Paladin close debt refinancing agreement and sign first licensing deal for Urocidin

Bioniche Life Sciences Inc. and Paladin Labs Inc. today announced the official closing of the various agreements associated with a comprehensive strategic collaboration to refinance and increase Bioniche's debt, provide new equity, and enter into the first licensing deal for Bioniche's Phase III bladder cancer product - Urocidin.

6 Jul 2013

3-gene signature test will improve care of kidney transplant patients

A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).

4 Jul 2013

Tel-Aviv research shows physicians delay diagnosis of cervical spondylotic myelopathy

Researchers from The Tel-Aviv Medical Center found delays in diagnosis of cervical spondylotic myelopathy (CSM) averaging 2 years in 42 patients who eventually underwent surgery. This is an important finding, because previous studies have shown that early diagnosis and treatment of CSM lead to better outcomes.

2 Jul 2013

Study: Active surveillance does not appear to be good idea for black men with prostate cancer

A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.

26 Jun 2013

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.

21 Jun 2013

Urology News and Research

Latest Urology News and Research

FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis

Both milky spots and fat cells in omentum promote ovarian cancer metastases

Thomas Jefferson University Hospital among nation's best hospitals

U.S. News & World Report ranks UC San Diego Health System among nation’s best hospitals

Houston Methodist Hospital again named No. 1 hospital in Texas

UCSF Medical Center named one of nation's premier hospitals for 12th consecutive year

TAp73 protein frequently overexpressed in wide range of human tumors

OncoGenex completes enrollment in OGX-427 Phase 2 trial for treatment of metastatic bladder cancer

Actavis’ Lamictal ODT drug receives FDA approval for treatment of epilepsy and bipolar disorder

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Proteins involved in immunity produce cancer-causing DNA mutations, study finds

Actavis receives FDA approval for Opana ER tablets

Researchers discover that APOBEC3B is important cancer mutagen

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer: an interview with Dr. Stephen Williams of St. Joseph Hospital in Orange

Robotic ultrasound to identify tumors during kidney cancer surgery gains acceptance among surgeons

Bioniche, Paladin close debt refinancing agreement and sign first licensing deal for Urocidin

3-gene signature test will improve care of kidney transplant patients

Tel-Aviv research shows physicians delay diagnosis of cervical spondylotic myelopathy

Study: Active surveillance does not appear to be good idea for black men with prostate cancer

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Urology News and Research

Latest Urology News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in